Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing

Georgios I Laliotis; Evangelia Chavdoula; Maria D Paraskevopoulou; Abdul Kaba; Alessandro La Ferlita; Satishkumar Singh; Vollter Anastas; Keith A Nair 2nd; Arturo Orlacchio; Vasiliki Taraslia; Ioannis Vlachos; Marina Capece; Artemis Hatzigeorgiou; Dario Palmieri; Christos Tsatsanis; Salvatore Alaimo; Lalit Sehgal; David P Carbone; Vincenzo Coppola; Philip N Tsichlis

doi:10.1038/s41467-022-31445-7

Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing

Nat Commun. 2022 Jun 28;13(1):3711. doi: 10.1038/s41467-022-31445-7.

Authors

Georgios I Laliotis^{1

2

3

4}, Evangelia Chavdoula^{5

6}, Maria D Paraskevopoulou⁷, Abdul Kaba^{5

6}, Alessandro La Ferlita^{5

6

8}, Satishkumar Singh^{6

9}, Vollter Anastas^{5

6

10}, Keith A Nair 2nd^{5

6}, Arturo Orlacchio^{5

6}, Vasiliki Taraslia^{7

11}, Ioannis Vlachos^{12

13}, Marina Capece^{5

6}, Artemis Hatzigeorgiou¹², Dario Palmieri^{5

6}, Christos Tsatsanis^{14

15}, Salvatore Alaimo⁸, Lalit Sehgal^{6

9}, David P Carbone^{6

16}, Vincenzo Coppola^{5

6}, Philip N Tsichlis^{17

18

19}

Affiliations

¹ Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. glaliot1@jhmi.edu.
² The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA. glaliot1@jhmi.edu.
³ School of Medicine, University of Crete, Heraklion, Crete, Greece. glaliot1@jhmi.edu.
⁴ Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA. glaliot1@jhmi.edu.
⁵ Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
⁶ The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
⁷ Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA.
⁸ Department of Clinical and Experimental Medicine, Bioinformatics Unit, University of Catania, Catania, Italy.
⁹ Department of Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
¹⁰ Tufts Graduate School of Biomedical Sciences, Program in Genetics, Boston, MA, USA.
¹¹ Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
¹² DIANA-Lab, Hellenic Pasteur Institute, Athens, Greece.
¹³ Department of Pathology, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
¹⁴ School of Medicine, University of Crete, Heraklion, Crete, Greece.
¹⁵ Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, Heraklion, Crete, Greece.
¹⁶ Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Medical Center, Columbus, OH, USA.
¹⁷ Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. Philip.tsichlis@osumc.edu.
¹⁸ The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA. Philip.tsichlis@osumc.edu.
¹⁹ Tufts Graduate School of Biomedical Sciences, Program in Genetics, Boston, MA, USA. Philip.tsichlis@osumc.edu.

No abstract available

Publication types

Retraction of Publication